Dorothée Alice Marie-Eve Bardiot
31Patents
4h-index
28Co-inventors
59Inventor score
Filing activity: May 17, 2010 → Oct 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9944598B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US10029984B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US10206902B2 | Mono- or di-substituted indoles as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US11851422B2 | Anti-viral compounds | Chemistry; Metallurgy | 6 | Active |
| US10689340B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US8785638B2 | Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10919854B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10696632B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10550123B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US11827602B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11180450B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11952365B2 | Anti-viral compounds | Chemistry; Metallurgy | 1 | Active |
| US12065428B2 | Anti-viral compounds | Chemistry; Metallurgy | 1 | Active |
| US11566025B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9499563B2 | Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10730884B2 | Substituted indole compound derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11279704B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10633378B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12012411B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11795149B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11407715B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10913716B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11702387B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11179368B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12252481B2 | Anti-viral compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.